Risk of second primary malignancies in patients with chronic lymphocytic leukemia:a population-based study in the Netherlands, 1989-2019

The longevity of patients with chronic lymphocytic leukemia (CLL) has improved progressively over the past decades, making it essential to understand long-term health outcomes, such as second primary malignancies (SPMs). Therefore, this nationwide, population-based study assessed the risk of SPM development in CLL patients diagnosed during 1989-2019 in the Netherlands compared to the expected number of malignancies in an age-, sex-, and period-matched group from the general Dutch population. In 24,815 CLL patients followed for 162,698.49 person-years, 4369 SPMs were diagnosed with a standardiz... Mehr ...

Verfasser: van der Straten, Lina
Levin, Mark David
Dinnessen, Manette A.W.
Visser, Otto
Posthuma, Eduardus F.M.
Doorduijn, Jeanette K.
Langerak, Anton W.
Kater, Arnon P.
Dinmohamed, Avinash G.
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Reihe/Periodikum: van der Straten , L , Levin , M D , Dinnessen , M A W , Visser , O , Posthuma , E F M , Doorduijn , J K , Langerak , A W , Kater , A P & Dinmohamed , A G 2023 , ' Risk of second primary malignancies in patients with chronic lymphocytic leukemia : a population-based study in the Netherlands, 1989-2019 ' , Blood Cancer Journal , vol. 13 , no. 1 , 15 . https://doi.org/10.1038/s41408-023-00784-z
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26840871
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://pure.eur.nl/en/publications/cd681877-7428-4a4f-a271-3beb0b7ebafe